Insiders · TRDA

Dipal Doshi

CEO, Director at Entrada Therapeutics, Inc. (TRDA)

Dipal Doshi has filed 48 insider reports with the SEC since November 2021, as CEO and director at Entrada Therapeutics, Inc. (TRDA) and director at Azenta, Inc. (AZTA). Dipal Doshi made no open-market purchases or sales in the last 12 months. The latest filing, on September 3, 2026, reports shares withheld for taxes or exercise price at Entrada Therapeutics, Inc. (TRDA).

Filings
48
Companies
2
Bought on market
None
Sold on market
$1.39M

Companies where Dipal Doshi is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Entrada Therapeutics, Inc. logo
TRDA
Entrada Therapeutics, Inc.
CEO, Director517,290$1.39M$4.35Sep 3, 2026
Azenta, Inc. logo
AZTA
Azenta, Inc.
Directorsince January 20259,703$44.80Feb 6, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Dipal Doshi with

Other insiders at the same companies

Questions about Dipal Doshi

What is Dipal Doshi's role at Entrada Therapeutics, Inc.?
Dipal Doshi reports to the SEC as CEO and director at Entrada Therapeutics, Inc. (TRDA), according to the latest filing on September 3, 2026. Dipal Doshi has also filed as director at Azenta, Inc. (AZTA).
How many shares does Dipal Doshi own?
After the latest filing that states it, Dipal Doshi directly owned 517,290 shares of Entrada Therapeutics, Inc. (TRDA) and 9,703 shares of Azenta, Inc. (AZTA). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Dipal Doshi bought or sold stock recently?
The most recent open-market sale was on July 15, 2024: sold 1,900 shares of Entrada Therapeutics, Inc. (TRDA) for $33.9K at an average of $17.84.
How do I get alerts when Dipal Doshi files?
Follow Dipal Doshi on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Dipal Doshi filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Dipal Doshi (SEC CIK 0001613084). Totals count each trade once, skipping amendments whose original is on file, from Nov 1, 2021 on. View on SEC EDGAR · Get this as JSON